Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma

The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Robert F., Miller, Merlin G., Cronin, John F., Hensley, Harvey H., Joshi, Indira D., Smith, Mitchell R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522695/
https://www.ncbi.nlm.nih.gov/pubmed/23272153
http://dx.doi.org/10.1371/journal.pone.0051736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522695/
https://www.ncbi.nlm.nih.gov/pubmed/23272153
http://dx.doi.org/10.1371/journal.pone.0051736

Ejemplares similares